Apnimed.png
Apnimed Announces First Patient Dosed in LunAIRo, the First Phase 3 Clinical Study of AD109, a Potential Nighttime Oral Treatment for Obstructive Sleep Apnea
September 21, 2023 05:30 ET | Apnimed, Inc.
-- LunAIRo Compares AD109 to Placebo Over 6 and 12 Months in People with OSA who Are Intolerant of or Refuse Positive Airway Pressure (PAP) Therapy, the Current Standard of Care -- -- Second...
Transparency Market Research
Non-invasive Ventilators Market to Grow at a CAGR of 5.9% during the 2022 to 2031 Forecast Period: TMR Study
July 26, 2023 09:00 ET | Transparency Market Research
Wilmington, Delaware, United States, July 26, 2023 (GLOBE NEWSWIRE) -- The global non-invasive ventilators market stood at US$ 2.2 billion in 2022 and the global market is projected to reach US$ 3.9...
PRO3-420-A ProSomnus, Inc Logo_horizontal.png
ProSomnus Announces Second Quarter 2023 Investor Call and Business Update
July 06, 2023 08:29 ET | ProSomnus Sleep Technologies, Inc.
PLEASANTON, Calif., July 06, 2023 (GLOBE NEWSWIRE) -- ProSomnus, Inc. (NASDAQ: OSA), a leading CPAP alternative for the treatment of Obstructive Sleep Apnea (“OSA”), will report its strong second...
Somnoware-LinkedIn-1200x670 (1).jpg
ResMed Acquires Somnoware, a Leader in Digital Sleep and Respiratory Care Diagnostics Software
July 05, 2023 16:05 ET | ResMed Inc.
Expands ResMed’s sleep management software solution, will help sleep labs and physicians more efficiently guide patients into and through diagnosis to long-term treatmentDiagnostic management platform...
ResMed logo-fullcolor.jpg
PAP Adherence Lowers ER Visits 24-36% in 1 Year for People with Sleep Apnea and Heart Failure: ResMed Studies Presented at SLEEP
June 08, 2023 09:00 ET | ResMed Inc.
The studies also showed 18-40% lower costs incurred from ER visits and hospitalizations after 1 year for PAP-adherent OSA patients with diastolic and systolic heart failure, respectivelyA third study...
22157.jpg
Noninvasive Ventilators and Airway Management Accessories Global Market Report 2023: Increasing Awareness Regarding the Health Benefits of CPAP Therapy Bolsters Sector
May 30, 2023 06:18 ET | Research and Markets
Dublin, May 30, 2023 (GLOBE NEWSWIRE) -- The "Noninvasive Ventilators and Airway Management Accessories" report has been added to ResearchAndMarkets.com's offering. The two most common...
ResMed logo-fullcolor.jpg
3 World-Renowned Sleep Apnea Experts Present New Benefits of PAP Therapies at ATS 2023
May 25, 2023 09:00 ET | ResMed Inc.
France’s Jean-Louis Pépin and Germany’s Holger Woehrle presented studies in which treating OSA with CPAP lowered all-cause mortality for PAP vs. non-PAP users with OSAGermany’s Michael Arzt presented...
NoxT3s_NoxRIP2
UPDATE--Nox Medical Secures New Patent for Calculating Respiratory Effort During Sleep Studies
April 05, 2023 16:31 ET | Nox Health
ALPHARETTA, Ga., April 05, 2023 (GLOBE NEWSWIRE) -- Nox Medical has secured a new patent to measure breathing movements for determining endophenotypes of sleep-disordered breathing using Nox RIP...
MicrosoftTeams-image (5).png
Tracheostomy Devices Market Size to Cross USD 291.3 Mn Revenue by 2031 Due to the Rise in Demand for Homecare Services | TMR Study
April 04, 2023 17:30 ET | Transparency Market Research
Wilmington, Delaware, United States, April 05, 2023 (GLOBE NEWSWIRE) -- According to Transparency Market Research, the global tracheostomy devices market size was valued at USD 203.7 Mn in 2021 and...
NoxT3s_NoxRIP2
Nox Medical Secures New Patent for Calculating Respiratory Effort During Sleep Studies
April 04, 2023 15:53 ET | Nox Health
ALPHARETTA, Ga., April 04, 2023 (GLOBE NEWSWIRE) -- The United States Patent Office recently granted Nox Medical a new patent for methods supporting accurate diagnoses of sleep apnea, which are...